The report provides information on the key drivers and challenges of the Diabetic Foot Ulcers Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Diabetic Foot Ulcers Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Diabetic Foot Ulcers Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Diabetic Foot Ulcers Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Diabetic Foot Ulcers Therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Diabetic Foot Ulcers Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Diabetic Foot Ulcers Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Diabetic Foot Ulcers Therapeutics market landscape? – Identify, understand and capitalize.
Buy your copy of this report @ http://www.reportsnreports.com/reports/174216-diabetic-foot-ulcer-therapeutics-pipeline-assessment-and-market-forecasts-to-2019.html
List of Figures
Figure 1: The University of Texas - Diabetic Wound Classification System 9
Figure 2: Diabetic Foot Ulcer - Pathophysiology 14
Figure 3: Diabetic Foot Infections - Antibiotic Use According to Clinical Severity 16
Figure 4: Diabetic Foot Ulcer - Referral Pathway 17
Figure 5: Diabetic Foot Infection Therapeutics Market, Global, Revenue ($m), 2006-2011 19
Figure 6: Wound-healing Therapeutics Market, Global, Revenue ($m), 2006-2011 20
Figure 7: Diabetic Foot Infection Therapeutics Market, Global, Forecast ($m), 2011-2019 21
Figure 8: Wound-healing Therapeutics Market, Global, Forecast ($m), 2011-2019 22
Figure 9: Diabetic Foot Infection Therapeutics Market, The US, Revenue ($m), 2006-2011 23
Figure 10: Wound-healing Therapeutics Market, The US, Revenue ($m), 2006-2011 24
Figure 11: Diabetic Foot Infection Therapeutics Market, The US, Forecast ($m), 2011-2019 25
Figure 12: Wound-healing Therapeutics Market, The US, Forecast ($m), 2011-2019 26
Figure 13: Diabetic Foot Infection Therapeutics Market, France, Revenue ($m), 2006-2011 27
Figure 14: Wound-healing Therapeutics Market, France, Revenue ($m), 2006-2011 28
Figure 15: Diabetic Foot Infection Therapeutics Market, France, Forecast ($m), 2011-2019 29
Figure 16: Wound-healing Therapeutics Market, France, Forecast ($m), 2011-2019 30
Figure 17: Diabetic Foot Infection Therapeutics Market, Germany, Revenue ($m), 2006-2011 31
Figure 18: Wound-healing Therapeutics Market, Germany, Revenue ($m), 2006-2011 32
Figure 19: Diabetic Foot Infection Therapeutics Market, Germany, Forecast ($m), 2011-2019 33
Figure 20: Wound-healing Therapeutics Market, Germany, Forecast ($m), 2011-2019 34
Figure 21: Diabetic Foot Infection Therapeutics Market, Italy, Revenue ($m), 2006-2011 35
Figure 22: Wound-healing Therapeutics Market, Italy, Revenue ($m), 2006-2011 36
Figure 23: Diabetic Foot Infection Therapeutics Market, Italy, Forecast ($m), 2011-2019 37
Figure 24: Wound-healing Therapeutics Market, Italy, Forecast ($m), 2011-2019 38
Figure 25: Diabetic Foot Infection Therapeutics Market, Spain, Revenue ($m), 2006-2011 39
Figure 26: Wound-healing Therapeutics Market, Spain, Revenue ($m), 2006-2011 40
Figure 27: Diabetic Foot Infection Therapeutics Market, Spain, Forecast ($m), 2011-2019 41
Figure 28: Wound-healing Therapeutics Market, Spain, Forecast ($m), 2011-2019 42
Figure 29: Diabetic Foot Infection Therapeutics Market, The UK, Revenue ($m), 2006-2011 43
Figure 30: Wound-healing Therapeutics Market, The UK, Revenue ($m), 2006-2011 44
Figure 31: Diabetic Foot Infection Therapeutics Market, The UK, Forecast ($m), 2011-2019 45
Figure 32: Wound-healing Therapeutics Market, The UK, Forecast ($m), 2011-2019 46
Figure 33: Diabetic Foot Infection Therapeutics Market, Japan, Revenue ($m), 2006-2011 47
Figure 34: Wound-healing Therapeutics Market, Japan, Revenue ($m), 2006-2011 48
Figure 35: Diabetic Foot Infection Therapeutics Market, Japan, Forecast ($m), 2011-2019 49
Figure 36: Wound-healing Therapeutics Market, Japan, Forecast ($m), 2011-2019 50
Figure 37: Diabetic Foot Ulcer Therapeutics Market, Drivers and Barriers, 2012 52
Figure 38: Opportunity and Unmet Need in Diabetic Foot Infection Therapeutics Market, 2012 53
Figure 39: Opportunity and Unmet Need in the Diabetic Foot Ulcer Wound-healing Therapeutics Market, 2012 54
Figure 40: Strategic Competitor Assessment of the Marketed Products in Diabetic Foot Ulcer Therapeutics, 2012 56
Figure 41: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Mechanism of Action (%), 2012 65
Figure 42: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Phase of Development (%), 2012 66
Figure 43: Technology Trends Analytics Framework, 2012 67
Figure 44: Technology Trends Analytics Framework - Description, 2012 68
Figure 45: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Country, 2012 72
Figure 46: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Phase (%), 2012 73
Figure 47: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Status of Development (%), 2012 74
Figure 48: Diabetic Foot Ulcer Therapeutics, Global, Overall Sponsors (%), 2012 75
Figure 49: Diabetic Foot Ulcer Therapeutics, Global, Prominent Sponsors (%), 2012 76
Figure 50: Diabetic Foot Ulcer Therapeutics, Global, Top Companies by Phase, 2012 77
Figure 51: Diabetic Foot Ulcer Therapeutics Market, Impact Analysis, 2012 78
Figure 52: Implications for Future Market Competition in the Diabetic Foot Ulcer Therapeutics Market, 2012 79
Figure 53: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Company, 2012 81
Figure 54: GlobalData Market Size Estimation 93
Figure 55: GlobalData Market Forecasting Model 95
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Diabetic Foot Ulcers Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Diabetic Foot Ulcers Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Diabetic Foot Ulcers Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Diabetic Foot Ulcers Therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Diabetic Foot Ulcers Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Diabetic Foot Ulcers Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Diabetic Foot Ulcers Therapeutics market landscape? – Identify, understand and capitalize.
Buy your copy of this report @ http://www.reportsnreports.com/reports/174216-diabetic-foot-ulcer-therapeutics-pipeline-assessment-and-market-forecasts-to-2019.html
Report Details:
Published: July 2012
No. of Pages: 96
No. of Pages: 96
Price: Single User License – US$3995 Corporate User License – US$11985
List of Figures
Figure 1: The University of Texas - Diabetic Wound Classification System 9
Figure 2: Diabetic Foot Ulcer - Pathophysiology 14
Figure 3: Diabetic Foot Infections - Antibiotic Use According to Clinical Severity 16
Figure 4: Diabetic Foot Ulcer - Referral Pathway 17
Figure 5: Diabetic Foot Infection Therapeutics Market, Global, Revenue ($m), 2006-2011 19
Figure 6: Wound-healing Therapeutics Market, Global, Revenue ($m), 2006-2011 20
Figure 7: Diabetic Foot Infection Therapeutics Market, Global, Forecast ($m), 2011-2019 21
Figure 8: Wound-healing Therapeutics Market, Global, Forecast ($m), 2011-2019 22
Figure 9: Diabetic Foot Infection Therapeutics Market, The US, Revenue ($m), 2006-2011 23
Figure 10: Wound-healing Therapeutics Market, The US, Revenue ($m), 2006-2011 24
Figure 11: Diabetic Foot Infection Therapeutics Market, The US, Forecast ($m), 2011-2019 25
Figure 12: Wound-healing Therapeutics Market, The US, Forecast ($m), 2011-2019 26
Figure 13: Diabetic Foot Infection Therapeutics Market, France, Revenue ($m), 2006-2011 27
Figure 14: Wound-healing Therapeutics Market, France, Revenue ($m), 2006-2011 28
Figure 15: Diabetic Foot Infection Therapeutics Market, France, Forecast ($m), 2011-2019 29
Figure 16: Wound-healing Therapeutics Market, France, Forecast ($m), 2011-2019 30
Figure 17: Diabetic Foot Infection Therapeutics Market, Germany, Revenue ($m), 2006-2011 31
Figure 18: Wound-healing Therapeutics Market, Germany, Revenue ($m), 2006-2011 32
Figure 19: Diabetic Foot Infection Therapeutics Market, Germany, Forecast ($m), 2011-2019 33
Figure 20: Wound-healing Therapeutics Market, Germany, Forecast ($m), 2011-2019 34
Figure 21: Diabetic Foot Infection Therapeutics Market, Italy, Revenue ($m), 2006-2011 35
Figure 22: Wound-healing Therapeutics Market, Italy, Revenue ($m), 2006-2011 36
Figure 23: Diabetic Foot Infection Therapeutics Market, Italy, Forecast ($m), 2011-2019 37
Figure 24: Wound-healing Therapeutics Market, Italy, Forecast ($m), 2011-2019 38
Figure 25: Diabetic Foot Infection Therapeutics Market, Spain, Revenue ($m), 2006-2011 39
Figure 26: Wound-healing Therapeutics Market, Spain, Revenue ($m), 2006-2011 40
Figure 27: Diabetic Foot Infection Therapeutics Market, Spain, Forecast ($m), 2011-2019 41
Figure 28: Wound-healing Therapeutics Market, Spain, Forecast ($m), 2011-2019 42
Figure 29: Diabetic Foot Infection Therapeutics Market, The UK, Revenue ($m), 2006-2011 43
Figure 30: Wound-healing Therapeutics Market, The UK, Revenue ($m), 2006-2011 44
Figure 31: Diabetic Foot Infection Therapeutics Market, The UK, Forecast ($m), 2011-2019 45
Figure 32: Wound-healing Therapeutics Market, The UK, Forecast ($m), 2011-2019 46
Figure 33: Diabetic Foot Infection Therapeutics Market, Japan, Revenue ($m), 2006-2011 47
Figure 34: Wound-healing Therapeutics Market, Japan, Revenue ($m), 2006-2011 48
Figure 35: Diabetic Foot Infection Therapeutics Market, Japan, Forecast ($m), 2011-2019 49
Figure 36: Wound-healing Therapeutics Market, Japan, Forecast ($m), 2011-2019 50
Figure 37: Diabetic Foot Ulcer Therapeutics Market, Drivers and Barriers, 2012 52
Figure 38: Opportunity and Unmet Need in Diabetic Foot Infection Therapeutics Market, 2012 53
Figure 39: Opportunity and Unmet Need in the Diabetic Foot Ulcer Wound-healing Therapeutics Market, 2012 54
Figure 40: Strategic Competitor Assessment of the Marketed Products in Diabetic Foot Ulcer Therapeutics, 2012 56
Figure 41: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Mechanism of Action (%), 2012 65
Figure 42: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Phase of Development (%), 2012 66
Figure 43: Technology Trends Analytics Framework, 2012 67
Figure 44: Technology Trends Analytics Framework - Description, 2012 68
Figure 45: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Country, 2012 72
Figure 46: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Phase (%), 2012 73
Figure 47: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Status of Development (%), 2012 74
Figure 48: Diabetic Foot Ulcer Therapeutics, Global, Overall Sponsors (%), 2012 75
Figure 49: Diabetic Foot Ulcer Therapeutics, Global, Prominent Sponsors (%), 2012 76
Figure 50: Diabetic Foot Ulcer Therapeutics, Global, Top Companies by Phase, 2012 77
Figure 51: Diabetic Foot Ulcer Therapeutics Market, Impact Analysis, 2012 78
Figure 52: Implications for Future Market Competition in the Diabetic Foot Ulcer Therapeutics Market, 2012 79
Figure 53: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Company, 2012 81
Figure 54: GlobalData Market Size Estimation 93
Figure 55: GlobalData Market Forecasting Model 95
